This compound is a protected morpholino cytosine monomer intermediate specifically designed for oligonucleotide synthesis. Its structure features a trityl-protected morpholino ring and a benzamide-protected cytosine base, making it suitable for solid-phase synthesis of morpholino phosphorodiamidate oligomers.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 125515-31-3
1-N-Boc-4-(Phenylamino)piperidine
pharmaceutical intermediate
N1-(5-Chloro-2-pyridinyl)-N2-((1S,2R,4R)-4-((dimethylamino)carbonyl)-2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)ethanediamide
pharmaceutical intermediate
1-[2-[2-[2-[2-[2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-methoxyethane
pharmaceutical intermediate
4-Amino-3,3-difluoro-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
pharmaceutical intermediate
(6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate)
research compound
N-[1-[(2R,6S)-6-(hydroxymethyl)-4-tritylmorpholin-2-yl]-2-oxopyrimidin-4-yl]benzamide
DMFVVKPXZHMPKX-XDFJSJKPSA-N
C1[C@H](O[C@H](CN1C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)CO
—